Research supports toxoplasmosis link to schizophrenia

Mar 11, 2009
This is a toxoplasma cyst outlined in red fluorescent cyst dye in mouse brain section. Hundreds of parasites are visible in the cyst as blue dots (nuclei stained blue) and in surrounding brain tissue. Image courtesy of E. Prandovszky

Scientists have discovered how the toxoplasmosis parasite may trigger the development of schizophrenia and other bipolar disorders.

The team from the University of Leeds' Faculty of Biological Sciences (UK) has shown that the parasite may play a role in the development of these disorders by affecting the production of dopamine - the chemical that relays messages in the controlling aspects of movement, cognition and behaviour.

, which is transmitted via cat faeces (found on unwashed vegetables) and raw or undercooked infected meat, is relatively common, with 10-20% of the UK population and 22% of the US population estimated to carry the parasite as cysts. Most people with the parasite are healthy, but for those who are immune-suppressed - and particularly for pregnant women - there are significant health risks that can occasionally be fatal.

Dr Glenn McConkey, lead researcher on the project, says: "Toxoplasmosis changes some of the chemical messages in the brain, and these changes can have an enormous effect on behaviour. Studies have shown there is a direct statistical link between incidences of and toxoplasmosis infection and our study is the first step in discovering why there is this link."

The parasite infects the brain by forming a cyst within its cells and produces an enzyme called tyrosine hydroxylase, which is needed to make dopamine. Dopamine's role in mood, sociability, attention, motivation and sleep patterns are well documented and schizophrenia has long been associated with dopamine, which is the target of all schizophrenia drugs on the market.

The team has recently received $250,000 (£160,000) to progress its research from the US-based Stanley Medical Research Institute, which focuses on mental health conditions and has a particular emphasis on bipolar illnesses.

Dr McConkey says: "It's highly unlikely that we will find one definitive trigger for schizophrenia as there are many factors involved, but our studies will provide a clue to how toxoplasmosis infection - which is more common than you might think - can impact on the development of the condition in some individuals.

"In addition, the ability of the parasite to make dopamine implies a potential link with other neurological conditions such as Parkinson's Disease, Tourette's syndrome and attention deficit disorders, says Dr McConkey. "We'd like to extend our research to look at this possibility more closely."

Source: University of Leeds

Explore further: Global Ebola toll rises to 5,689: WHO

add to favorites email to friend print save as pdf

Related Stories

US struggles to pinpoint cyber attacks: Top official

Mar 10, 2009

The United States often cannot quickly or reliably trace a cyber attack back to its source, even as rival nations and extremists may be looking to wage virtual war, a top official warned Tuesday.

Hewlett Packard to create 500 jobs in Ireland

Mar 10, 2009

US technology company Hewlett Packard is to create 500 jobs with an 18-million-euro (23-million-dollar) expansion of its global service desk operation in Leixlip, County Kildare southwest of Dublin, Prime ...

Can mental training games help prevent Alzheimer's?

Mar 10, 2009

Loss of thinking power is a fear shared by many aging baby boomers. That fear has resulted in a budding industry for brain training products - exercises such as Brain Age, Mindfit and My Brain Trainer - which in 2007 generated ...

Recommended for you

Global Ebola toll rises to 5,689: WHO

3 hours ago

The World Health Organization said Thursday that the global death toll from the Ebola virus had increased to 5,689 out of a total of 15,935 cases of infection, mainly in western Africa.

Ebola vaccine promising in first human trials

13 hours ago

Researchers say they're a step closer to developing an Ebola vaccine, with a Phase 1 trial showing promising results, but it will be months at the earliest before it can be used in the field.

At one month, US Ebola monitors finding no cases

16 hours ago

The U.S. program that requires weeks of monitoring for travelers from African countries with Ebola reaches the one-month mark Thursday. And so far, no cases of the disease have turned up.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.